Showing results (191-200 of 617) with videos related to

Sort By:
Pageof 62
Blood Advances|July 28, 2019
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosisJason Gotlib, John H Baird, Tracy I George, et al.
Haematologica|March 30, 2013
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816VKaroline V Gleixner, Barbara Peter, Katharina Blatt, et al.
Leukemia|February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsBenjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.
Blood Neoplasia|December 22, 2025
Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinibEmily C Liang, Cecelia Perkins, Rong Lu, et al.
Archives of Orthopaedic and Trauma Surgery|September 17, 2008
Ulnar shortening after TFCC suture repair of Palmer type 1B lesionsMaya B Wolf, Markus W Kroeber, Andreas Reiter, et al.
Genes, Chromosomes & Cancer|March 25, 2026
Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6::ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor PrognosisBettina Balk, Marietta Truger, Wencke Walter, et al.
Pageof 62